サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1762269

医薬品賦形剤市場、規模、シェア、動向、産業分析レポート：製品別、剤形別、機能別、地域別、2025年～2034年の市場予測

Pharmaceutical Excipients Market Size, Share, Trends, Industry Analysis Report: By Product, Formulation, Functionality, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 117 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.89円
医薬品賦形剤市場、規模、シェア、動向、産業分析レポート：製品別、剤形別、機能別、地域別、2025年～2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の医薬品賦形剤市場規模は2034年までに202億2,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

医薬品賦形剤は、医薬品製剤に使用される不活性成分で、医薬品有効成分（API）の安定性、バイオアベイラビリティ、適切なドラッグデリバリーをサポートします。これらの物質は、充填剤、結合剤、崩壊剤、保存剤、コーティング剤など様々な機能を果たし、医薬品の効果的な生産と投与を保証します。賦形剤は、薬物の溶解性を高め、放出メカニズムを制御し、患者のコンプライアンスを向上させるという重要な役割を担っており、医薬品製造に欠かせないものとなっています。

医薬品賦形剤市場の成長は、医薬品生産の増加、ドラッグデリバリーシステムの進歩、ジェネリック医薬品や生物学的製剤の需要の高まりによってもたらされます。特に新興市場における製薬産業の拡大は、賦形剤メーカーに新たな機会をもたらしています。

多機能賦形剤の採用、天然由来で持続可能な賦形剤へのシフト、個別化医療への関心の高まりといった医薬品賦形剤市場の動向は、市場の展望を形成しています。さらに、賦形剤の安全性と有効性を保証する厳格な規制ガイドラインが、技術革新と品質向上を促しています。製剤の絶え間ない進化とヘルスケアニーズの高まりにより、医薬品賦形剤の需要は引き続き堅調に推移すると予想されます。

医薬品賦形剤市場レポートハイライト

製品別では、ポリマー、炭水化物、タンパク質など、医薬品製剤への広範な使用により、有機化学品セグメントが医薬品賦形剤市場で大きなシェアを占めています。天然由来の賦形剤や生体適合性成分への需要の高まりが、このセグメントの成長を牽引しています。

製剤別では、錠剤製剤が最も広く使用されているドラッグデリバリー形態として、製造の容易さ、患者のコンプライアンス、長い保存期間に支えられ、大きな成長が見込まれています。非経口剤形は、生物製剤や注射剤の需要の高まりにより、最も高い成長を遂げています。

地域別では、確立された製薬業界、厳格な規制の枠組み、製剤技術の継続的な進歩により、2024年の医薬品賦形剤市場の売上高シェアは欧州が独占しました。

アジア太平洋医薬品賦形剤市場は、医薬品製造の拡大、ヘルスケア支出の増加、有利な政府政策に牽引され、急速な成長を遂げています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の医薬品賦形剤市場の洞察

  • 市場スナップショット
  • 医薬品賦形剤市場力学
    • 促進要因と機会
      • 国内医薬品製造を促進する政府の取り組み
      • 臨床試験プロセスを強化する規制改革
    • 抑制要因と課題
      • 規制遵守と厳格な品質基準
  • PESTEL分析
  • 医薬品賦形剤市場のアプリケーション動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の医薬品賦形剤市場：製品別

  • 主な調査結果
  • イントロダクション
  • 無機化学品
  • 有機化学物質

第6章 世界の医薬品賦形剤市場：剤形別

  • 主な調査結果
  • イントロダクション
  • 錠剤
  • カプセル
  • 非経口
  • 液体
  • 経口

第7章 世界の医薬品賦形剤市場：機能別

  • 主な調査結果
  • イントロダクション
  • ブラインダーズ
  • 充填剤と希釈剤
  • 懸濁剤および増粘剤
  • 防腐剤
  • 香料・甘味料
  • コーティング剤

第8章 世界の医薬品賦形剤市場：地域別

  • 主な調査結果
  • イントロダクション
    • 医薬品賦形剤市場の評価：地域別、2020-2034年
  • 北米
    • 北米：製品別、2020～2034年
    • 北米：剤形別、2020～2034年
    • 北米：機能別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：製品別、2020～2034年
    • 欧州：剤形別、2020～2034年
    • 欧州：機能別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：製品別、2020～2034年
    • アジア太平洋地域：剤形別、2020～2034年
    • アジア太平洋地域：機能別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：製品別、2020～2034年
    • 中東・アフリカ：剤形別、2020～2034年
    • 中東・アフリカ：機能別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：製品別、2020～2034年
    • ラテンアメリカ：剤形別、2020～2034年
    • ラテンアメリカ：機能別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Archer Daniels Midland Company
  • Ashland Global Holdings Inc.
  • BASF SE
  • Colorcon, Inc.
  • Croda International Plc
  • DFE Pharma
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • JRS Pharma
  • Kerry Group plc
図表

List of Tables:

  • Table 1 Global Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 2 Global Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 3 Global Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 4 North America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 5 North America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 6 North America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 7 U.S.: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 8 U.S.: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 9 U.S.: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 10 Canada: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 11 Canada: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 12 Canada: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 13 Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 14 Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 15 Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 16 UK: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 17 UK: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 18 UK: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 19 France: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 20 France: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 21 France: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 22 Germany: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 23 Germany: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 24 Germany: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 25 Italy: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 26 Italy: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 27 Italy: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 28 Spain: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 29 Spain: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 30 Spain: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 34 Russia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Russia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 36 Russia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 43 China: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 44 China: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 45 China: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 46 India: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 47 India: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 48 India: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 52 Japan: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 53 Japan: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 54 Japan: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 58 South Korea: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 59 South Korea: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 60 South Korea: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 61 Australia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 62 Australia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 63 Australia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 73 UAE: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 74 UAE: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 75 UAE: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 76 Israel: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 77 Israel: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 78 Israel: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 79 South Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 80 South Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 81 South Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 85 Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 86 Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 87 Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 88 Mexico: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 89 Mexico: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 90 Mexico: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 91 Brazil: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 92 Brazil: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 93 Brazil: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 94 Argentina: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Argentina: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 96 Argentina: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Pharmaceutical Excipients Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Pharmaceutical Excipients Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Formulation
  • Figure 9. Global Pharmaceutical Excipients Market, by Formulation, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Functionality
  • Figure 11. Global Pharmaceutical Excipients Market, by Functionality, 2024 & 2034 (USD Billion)
目次
Product Code: PM3919

The global pharmaceutical excipients market size is expected to reach USD 20.22 billion by 2034, according to a new study by Polaris Market Research. The report "Pharmaceutical Excipients Market Size, Share, Trends, Industry Analysis Report: By Product (Inorganic Chemicals and Organic Chemicals), Formulation, Functionality, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Pharmaceutical excipients are inactive components used in drug formulations to support the active pharmaceutical ingredient (API) in achieving stability, bioavailability, and proper drug delivery. These substances serve various functions, such as fillers, binders, disintegrants, preservatives, and coating agents, ensuring the effective production and administration of pharmaceuticals. Excipients play a critical role in enhancing drug solubility, controlling release mechanisms, and improving patient compliance, making them indispensable in pharmaceutical manufacturing.

The pharmaceutical excipients market growth is driven by increasing pharmaceutical production, advancements in drug delivery systems, and the rising demand for generic and biologic medicines. The expansion of the pharmaceutical industry, particularly in emerging markets, is creating new opportunities for excipient manufacturers.

Pharmaceutical excipients market trends such as the adoption of multifunctional excipients, the shift toward naturally derived and sustainable excipients, and the growing focus on personalized medicine are shaping the market landscape. Additionally, stringent regulatory guidelines ensuring excipient safety and efficacy are encouraging innovation and quality improvements. With the continuous evolution of drug formulations and increasing healthcare needs, the demand for pharmaceutical excipients is expected to remain strong.

Pharmaceutical Excipients Market Report Highlights

By product, the organic chemicals segment holds a larger pharmaceutical excipients market share due to their extensive use in drug formulations, including polymers, carbohydrates, and proteins. The increasing demand for naturally derived excipients and biocompatible ingredients is driving the growth of this segment.

By formulation, the tablets formulation segment is expected to witness significant growth as the most widely used drug delivery format, supported by ease of manufacturing, patient compliance, and long shelf life. Parenteral formulation is experiencing the highest growth due to the rising demand for biologics and injectable drugs.

By region, Europe dominated the pharmaceutical excipients market revenue share in 2024 due to its well-established pharmaceutical industry, stringent regulatory framework, and continuous advancements in drug formulation technologies.

The Asia Pacific pharmaceutical excipients market is experiencing rapid growth, driven by expanding pharmaceutical manufacturing, increasing healthcare expenditures, and favorable government policies

The pharmaceutical excipients market features several prominent companies actively contributing to the industry. These include Lubrizol Corporation; Archer Daniels Midland Company; DuPont de Nemours, Inc.; BASF SE; Evonik Industries AG; Ashland Global Holdings Inc.; Roquette Freres; Kerry Group plc; Croda International Plc; DFE Pharma; JRS Pharma; Colorcon, Inc.; MEGGLE GmbH & Co. KG; Wacker Chemie AG; and Associated British Foods plc.

Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, functionality, and region:

By Product Outlook (Revenue-USD Billion, 2020-2034)

Inorganic Chemicals

Organic Chemicals

By Formulation Outlook (Revenue-USD Billion, 2020-2034)

Tablets Formulation

Capsules Formulation

Parental Formulation

Liquid Formulation

Oral Formulation

By Functionality Outlook (Revenue-USD Billion, 2020-2034)

Blinders

Fillers & Diluents

Suspending & Viscosity agents

Preservatives

Flavoring Agents & Sweeteners

Coating Agents

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Pharmaceutical Excipients Market Insights

  • 4.1. Pharmaceutical Excipients Market - Market Snapshot
  • 4.2. Pharmaceutical Excipients Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Government Initiatives Promoting Domestic Pharmaceutical Manufacturing
      • 4.2.1.2. Regulatory Reforms Enhancing Clinical Trial Processes
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Compliance and Stringent Quality Standards
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Pharmaceutical Excipients Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Pharmaceutical Excipients Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Inorganic Chemicals
    • 5.3.1. Global Pharmaceutical Excipients Market, by Inorganic Chemicals, by Region, 2020-2034 (USD Billion)
  • 5.4. Organic Chemicals
    • 5.4.1. Global Pharmaceutical Excipients Market, by Organic Chemicals, by Region, 2020-2034 (USD Billion)

6. Global Pharmaceutical Excipients Market, by Formulation

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
  • 6.3. Tablets Formulation
    • 6.3.1. Global Pharmaceutical Excipients Market, by Tablets Formulation, by Region, 2020-2034 (USD Billion)
  • 6.4. Capsules Formulation
    • 6.4.1. Global Pharmaceutical Excipients Market, by Capsules Formulation, by Region, 2020-2034 (USD Billion)
  • 6.5. Parental Formulation
    • 6.5.1. Global Pharmaceutical Excipients Market, by Parental Formulation, by Region, 2020-2034 (USD Billion)
  • 6.6. Liquid Formulation
    • 6.6.1. Global Pharmaceutical Excipients Market, by Liquid Formulation, by Region, 2020-2034 (USD Billion)
  • 6.7. Oral Formulation
    • 6.7.1. Global Pharmaceutical Excipients Market, by Oral Formulation, by Region, 2020-2034 (USD Billion)

7. Global Pharmaceutical Excipients Market, by Functionality

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • 7.3. Blinders
    • 7.3.1. Global Pharmaceutical Excipients Market, by Blinders, by Region, 2020-2034 (USD Billion)
  • 7.4. Fillers & Diluents
    • 7.4.1. Global Pharmaceutical Excipients Market, by Fillers & Diluents, by Region, 2020-2034 (USD Billion)
  • 7.5. Suspending & Viscosity agents
    • 7.5.1. Global Pharmaceutical Excipients Market, by Suspending & Viscosity agents, by Region, 2020-2034 (USD Billion)
  • 7.6. Preservatives
    • 7.6.1. Global Pharmaceutical Excipients Market, by Preservatives, by Region, 2020-2034 (USD Billion)
  • 7.7. Flavoring agents & Sweeteners
    • 7.7.1. Global Pharmaceutical Excipients Market, by Flavoring agents & Sweeteners, by Region, 2020-2034 (USD Billion)
  • 7.8. Coating agents
    • 7.8.1. Global Pharmaceutical Excipients Market, by Coating agents, by Region, 2020-2034 (USD Billion)

8. Global Pharmaceutical Excipients Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Pharmaceutical Excipients Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Pharmaceutical Excipients Market - North America
    • 8.3.1. North America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
    • 8.3.2. North America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
    • 8.3.3. North America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.3.4. Pharmaceutical Excipients Market - U.S.
      • 8.3.4.1. U.S.: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.3.5. Pharmaceutical Excipients Market - Canada
      • 8.3.5.1. Canada: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • 8.4. Pharmaceutical Excipients Market - Europe
    • 8.4.1. Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.4. Pharmaceutical Excipients Market - UK
      • 8.4.4.1. UK: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.5. Pharmaceutical Excipients Market - France
      • 8.4.5.1. France: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.6. Pharmaceutical Excipients Market - Germany
      • 8.4.6.1. Germany: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.7. Pharmaceutical Excipients Market - Italy
      • 8.4.7.1. Italy: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.8. Pharmaceutical Excipients Market - Spain
      • 8.4.8.1. Spain: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.9. Pharmaceutical Excipients Market - Netherlands
      • 8.4.9.1. Netherlands: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.10. Pharmaceutical Excipients Market - Russia
      • 8.4.10.1. Russia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.4.11. Pharmaceutical Excipients Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • 8.5. Pharmaceutical Excipients Market - Asia Pacific
    • 8.5.1. Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.4. Pharmaceutical Excipients Market - China
      • 8.5.4.1. China: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.5. Pharmaceutical Excipients Market - India
      • 8.5.5.1. India: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.6. Pharmaceutical Excipients Market - Malaysia
      • 8.5.6.1. Malaysia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.7. Pharmaceutical Excipients Market - Japan
      • 8.5.7.1. Japan: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.8. Pharmaceutical Excipients Market - Indonesia
      • 8.5.8.1. Indonesia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.9. Pharmaceutical Excipients Market - South Korea
      • 8.5.9.1. South Korea: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.10. Pharmaceutical Excipients Market - Australia
      • 8.5.10.1. Australia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.5.11. Pharmaceutical Excipients Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • 8.6. Pharmaceutical Excipients Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.6.4. Pharmaceutical Excipients Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.6.5. Pharmaceutical Excipients Market - UAE
      • 8.6.5.1. UAE: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.6.6. Pharmaceutical Excipients Market - Israel
      • 8.6.6.1. Israel: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.6.7. Pharmaceutical Excipients Market - South Africa
      • 8.6.7.1. South Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.6.8. Pharmaceutical Excipients Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
  • 8.7. Pharmaceutical Excipients Market - Latin America
    • 8.7.1. Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.7.4. Pharmaceutical Excipients Market - Mexico
      • 8.7.4.1. Mexico: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.7.5. Pharmaceutical Excipients Market - Brazil
      • 8.7.5.1. Brazil: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.7.6. Pharmaceutical Excipients Market - Argentina
      • 8.7.6.1. Argentina: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)
    • 8.7.7. Pharmaceutical Excipients Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Pharmaceutical Excipients Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Pharmaceutical Excipients Market, by Formulation, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Pharmaceutical Excipients Market, by Functionality, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Archer Daniels Midland Company
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Ashland Global Holdings Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. BASF SE
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Colorcon, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Croda International Plc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. DFE Pharma
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. DuPont de Nemours, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Evonik Industries AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. JRS Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Kerry Group plc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development